Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment to Tentative Final Monograph; Reopening of Comment Period

Summary

The US Food and Drug Administration (FDA) is reopening the comment period for proposed rulemaking on over-the-counter internal analgesic and antacid ingredients until May 4, 1994, in response to a 30-day extension request.